Trial · NCT02803749
Results by group16
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 16 of 16
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| The Number of Participants Who Fail to Complete the 12-week Study on Study Drug. | Buspirone | 7 | Participants | ||
| The Number of Participants Who Fail to Complete the 12-week Study on Study Drug. | Placebo | 0 | Participants | ||
| Mean Change in Hamilton Anxiety Rating Scale (HAM-A) From Baseline to 12 Weeks | Buspirone | -4.21 | Standard Error 1.13 | score on a scale | |
| Mean Change in Hamilton Anxiety Rating Scale (HAM-A) From Baseline to 12 Weeks | Placebo | -3.36 | Standard Error 1.97 | score on a scale | |
| Number of Responders (>50% Reduction From Baseline or Reduction to ≤7 on HAM-A) at 12 Weeks | Buspirone | 9 | Participants | ||
| Number of Responders (>50% Reduction From Baseline or Reduction to ≤7 on HAM-A) at 12 Weeks | Placebo | 1 | Participants | ||
| Number of Much Improved or Very Much Improved on Patient Global Impressions-Improvement (PGI-I) at 12 Weeks | Buspirone | 3 | Participants | ||
| Number of Much Improved or Very Much Improved on Patient Global Impressions-Improvement (PGI-I) at 12 Weeks | Placebo | 0 | Participants | ||
| Mean Change in Anxiety Using the Hospital Anxiety and Depression Scale (HADS) | Buspirone | -1.87 | Standard Error 0.98 | score on a scale | |
| Mean Change in Anxiety Using the Hospital Anxiety and Depression Scale (HADS) | Placebo | -0.89 | Standard Error 1.71 | score on a scale | |
| Mean Change in Unified Dyskinesia Rating Scale (UDysRS) From Baseline to 12 Weeks | Buspirone | .72 | Standard Error 3.22 | score on a scale | |
| Mean Change in Unified Dyskinesia Rating Scale (UDysRS) From Baseline to 12 Weeks | Placebo | 7.78 | Standard Error 6.44 | score on a scale | |
| Number of Much Improved or Very Much Improved on Clinical Global Impressions-Improvement (CGI-I) at 12 Weeks | Buspirone | 5 | Participants | ||
| Number of Much Improved or Very Much Improved on Clinical Global Impressions-Improvement (CGI-I) at 12 Weeks | Placebo | 2 | Participants | ||
| Mean Change in Hospital Anxiety and Depression Scale (HADS) - Depression From Baseline to 12 Weeks | Buspirone | -.95 | Standard Error .46 | units on a scale | |
| Mean Change in Hospital Anxiety and Depression Scale (HADS) - Depression From Baseline to 12 Weeks | Placebo | .34 | Standard Error .81 | units on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02803749/results